Galus K, Szymendera J, Zaleski A, Schreyer K
Calcif Tissue Int. 1980;31(3):209-13. doi: 10.1007/BF02407183.
The present study was undertaken to evaluate the effects of 1 alpha-hydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on bone remodeling in dogs with osteomalacia induced by vitamin D depletion. To assess the rates of skeletal remodeling, intravital tetracycline labeling and morphometry of surface pattern were employed. Either vitamin D3 derivative accelerated the appositional growth rate, increased the percentage of osteoid seams labeled, and decreased the number, width, and perimeter of new osteoid seams. But the derivatives differed in bone resorbing activity: 1 alpha-hydroxyvitamin D3 increased the number and perimeter of resorption sites whereas 24R,25-dihydroxyvitamin D3 decreased them. Thus the results show that the former is a better bone remodeler while the latter may be useful in treating osteoporosis.
本研究旨在评估1α-羟基维生素D3和24R,25-二羟基维生素D3对维生素D缺乏诱导的犬骨软化症骨重塑的影响。为评估骨骼重塑速率,采用了活体四环素标记和表面模式形态计量学方法。两种维生素D3衍生物均加速了骨沉积生长速率,增加了类骨质缝标记的百分比,并减少了新类骨质缝的数量、宽度和周长。但这两种衍生物在骨吸收活性方面存在差异:1α-羟基维生素D3增加了吸收部位的数量和周长,而24R,25-二羟基维生素D3则使其减少。因此,结果表明前者是更好的骨重塑剂,而后者可能对治疗骨质疏松症有用。